Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/27205
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | PAIVA, Arthur M. | - |
dc.contributor.author | ASSONE, Tatiane | - |
dc.contributor.author | HAZIOT, Michel E. J. | - |
dc.contributor.author | SMID, Jerusa | - |
dc.contributor.author | FONSECA, Luiz Augusto M. | - |
dc.contributor.author | LUIZ, Olinda do Carmo | - |
dc.contributor.author | OLIVEIRA, Augusto Cesar Penalva de | - |
dc.contributor.author | CASSEB, Jorge | - |
dc.date.accessioned | 2018-07-05T18:14:04Z | - |
dc.date.available | 2018-07-05T18:14:04Z | - |
dc.date.issued | 2018 | - |
dc.identifier.citation | SCIENTIFIC REPORTS, v.8, article ID 7742, 6p, 2018 | - |
dc.identifier.issn | 2045-2322 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/27205 | - |
dc.description.abstract | HTLV-1 is transmitted primarily either through sexual intercourse or from mother to child. The mother/child pairs were classified as seroconcordant or serodiscordant. We analyzed mother to child transmission (MTCT) according to sociodemographic, clinical and epidemiological characteristics of the mother, child's gender and duration of breastfeeding. Between June 2006 and August 2016 we followed 192 mothers with HTLV-1 infection (mean age 41 years old), resulting in 499 exposed offspring, 288 (57.7%) of whom were tested for HTLV-1, making up the final sample for the study, along with their 134 respective mothers. Among the tested mother/child pairs, 41 (14.2%) were HTLV-1 positive, highlighted that seven of 134 family clusters concentrated 48.8% of positive cases. Variables associated with a positive child: breastfeeding duration >= 12 months, maternal PVL >= 100 copies/10(4) PBMC, mother's age at delivery >26 years old, and HTLV-1 in more than one child of the same mother. In a multiple logistic regression, breastfeeding >= 12 months, higher maternal PVL and >= 2 previous HTLV-l-infected children remained independently associated with the outcome. Thus, high maternal PVL and breastfeeding beyond 12 months were independently associated with MTCT of the HTLV-1 infection. Our results reinforce the need for both prenatal HTLV screening in endemic areas and for advising mothers on breastfeeding. | - |
dc.description.sponsorship | FAPESP [2014/22827-7, 2016/03025-2] | - |
dc.language.iso | eng | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.relation.ispartof | Scientific Reports | - |
dc.rights | openAccess | - |
dc.subject.other | lymphotropic virus type-1 | - |
dc.subject.other | to-child transmission | - |
dc.subject.other | myelopathy/tropical spastic paraparesis | - |
dc.subject.other | sao-paulo city | - |
dc.subject.other | i infection | - |
dc.subject.other | pregnant-women | - |
dc.subject.other | population | - |
dc.subject.other | prevalence | - |
dc.subject.other | jamaica | - |
dc.subject.other | japan | - |
dc.title | Risk factors associated with HTLV-1 vertical transmission in Brazil: longer breastfeeding, higher maternal proviral load and previous HTLV-l-infected offspring | - |
dc.type | article | - |
dc.rights.holder | Copyright NATURE PUBLISHING GROUP | - |
dc.identifier.doi | 10.1038/s41598-018-25939-y | - |
dc.identifier.pmid | 29773807 | - |
dc.subject.wos | Multidisciplinary Sciences | - |
dc.type.category | original article | - |
dc.type.version | publishedVersion | - |
hcfmusp.author.external | HAZIOT, Michel E. J.:Secretaria Saude Estado Sao Paulo, Inst Infectol Emilio Ribas, Sao Paulo, SP, Brazil | - |
hcfmusp.author.external | SMID, Jerusa:Secretaria Saude Estado Sao Paulo, Inst Infectol Emilio Ribas, Sao Paulo, SP, Brazil | - |
hcfmusp.author.external | OLIVEIRA, Augusto Cesar Penalva de:Secretaria Saude Estado Sao Paulo, Inst Infectol Emilio Ribas, Sao Paulo, SP, Brazil | - |
hcfmusp.description.articlenumber | 7742 | - |
hcfmusp.description.volume | 8 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | WOS:000432339100005 | - |
hcfmusp.origem.id | 2-s2.0-85047253211 | - |
hcfmusp.publisher.city | LONDON | - |
hcfmusp.publisher.country | ENGLAND | - |
hcfmusp.relation.reference | Alarcón Villaverde Jorge, 2011, Rev. perú. med. exp. salud publica, V28, P101, DOI 10.1590/s1726-46342011000100016 | - |
hcfmusp.relation.reference | Arango C., 1998, BRAZ J INFECT DIS, V2, P135 | - |
hcfmusp.relation.reference | BITTENCOURT Achiléa L, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P63, DOI 10.1590/S0036-46652002000200002 | - |
hcfmusp.relation.reference | Catalan-Soares Bernadette, 2005, Cad. Saúde Pública, V21, P926, DOI 10.1590/S0102-311X2005000300027 | - |
hcfmusp.relation.reference | Costa C. A. D, 2013, PLOS NEGL TROP DIS, V7 | - |
hcfmusp.relation.reference | Dehee A, 2002, J VIROL METHODS, V102, P37, DOI 10.1016/S0166-0934(01)00445-1 | - |
hcfmusp.relation.reference | DETHE G, 1993, AIDS RES HUM RETROV, V9, P381, DOI 10.1089/aid.1993.9.381 | - |
hcfmusp.relation.reference | Furnia A, 1999, J MED VIROL, V59, P541, DOI 10.1002/(SICI)1096-9071(199912)59:4<541::AID-JMV19>3.0.CO;2-S | - |
hcfmusp.relation.reference | Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388 | - |
hcfmusp.relation.reference | Mello MAG, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-28 | - |
hcfmusp.relation.reference | Gotuzzo E, 2007, REV PANAM SALUD PUBL, V22, P223, DOI 10.1590/S1020-49892007000900001 | - |
hcfmusp.relation.reference | Hamedi A., 2012, ISRN OBSTET GYNECOL, V2012 | - |
hcfmusp.relation.reference | Hedayati-Moghaddam MR, 2015, VIRUSES-BASEL, V7, P5736, DOI 10.3390/v7112904 | - |
hcfmusp.relation.reference | Hino S, 2011, P JPN ACAD B-PHYS, V87, P152, DOI 10.2183/pjab.87.152 | - |
hcfmusp.relation.reference | Hisada M, 2005, J INFECT DIS, V191, P1781, DOI 10.1086/429753 | - |
hcfmusp.relation.reference | Hisada M, 2002, CLIN INFECT DIS, V34, P1551, DOI 10.1086/340537 | - |
hcfmusp.relation.reference | KAJIYAMA W, 1986, J INFECT DIS, V154, P851, DOI 10.1093/infdis/154.5.851 | - |
hcfmusp.relation.reference | Kashiwagi K, 2004, AM J TROP MED HYG, V70, P158 | - |
hcfmusp.relation.reference | MONPLAISIR N, 1993, AIDS RES HUM RETROV, V9, P869, DOI 10.1089/aid.1993.9.869 | - |
hcfmusp.relation.reference | Montanheiro P, 2008, VIRUS RES, V135, P22, DOI 10.1016/j.virusres.2008.01.015 | - |
hcfmusp.relation.reference | Montanheito PA, 2005, BRAZ J MED BIOL RES, V38, P1643, DOI 10.1590/S0100-879X2005001100011 | - |
hcfmusp.relation.reference | Montano SM, 2004, CLIN INFECT DIS, V39, P1079, DOI 10.1086/424017 | - |
hcfmusp.relation.reference | Moriuchi H, 2013, PEDIATR INFECT DIS J, V32, P175, DOI 10.1097/INF.0b013e31827efc39 | - |
hcfmusp.relation.reference | Novoa P, 2007, J MED VIROL, V79, P182, DOI 10.1002/jmv.20775 | - |
hcfmusp.relation.reference | Nunes D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171303 | - |
hcfmusp.relation.reference | Nyambi PN, 1996, J ACQ IMMUN DEF SYND, V12, P187, DOI 10.1097/00042560-199606010-00013 | - |
hcfmusp.relation.reference | Paiva A, 2014, REV SOC BRAS MED TRO, V47, P265, DOI 10.1590/0037-8682-0232-2013 | - |
hcfmusp.relation.reference | Percher F, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8020040 | - |
hcfmusp.relation.reference | Plancoulaine S, 2000, J INFECT DIS, V182, P405, DOI 10.1086/315741 | - |
hcfmusp.relation.reference | Proietti FA, 2005, ONCOGENE, V24, P6058, DOI 10.1038/sj.onc.1208968 | - |
hcfmusp.relation.reference | Ribeiro MA, 2012, PEDIATR INFECT DIS J, V31, P1139, DOI 10.1097/INF.0b013e318263215e | - |
hcfmusp.relation.reference | Takahashi K., 1991, INHIBITORY EFFECT MA, V677, P673 | - |
hcfmusp.relation.reference | Ureta-Vidal A, 1999, INT J CANCER, V82, P832, DOI 10.1002/(SICI)1097-0215(19990909)82:6<832::AID-IJC11>3.0.CO;2-P | - |
hcfmusp.relation.reference | van Tienen C, 2012, AIDS RES HUM RETROV, V28, P584, DOI [10.1089/aid.2011.0219, 10.1089/AID.2011.0219] | - |
hcfmusp.relation.reference | van Tienen C, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-50 | - |
hcfmusp.relation.reference | Wiktor S Z, 1997, J Hum Virol, V1, P37 | - |
hcfmusp.relation.reference | Willems L, 2017, ANTIVIR RES, V137, P41, DOI 10.1016/j.antiviral.2016.10.015 | - |
hcfmusp.relation.reference | Yamada T, 2014, MICROBIOL IMMUNOL, V58, P427, DOI 10.1111/1348-0421.12165 | - |
dc.description.index | MEDLINE | - |
hcfmusp.citation.scopus | 42 | - |
hcfmusp.scopus.lastupdate | 2024-04-11 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - IMT Artigos e Materiais de Revistas Científicas - LIM/38 Artigos e Materiais de Revistas Científicas - LIM/56 Artigos e Materiais de Revistas Científicas - ODS/05 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_PAIVA_Risk_factors_associated_with_HTLV1_vertical_transmission_in_2018.PDF | publishedVersion (English) | 1.06 MB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.